Taiho Pharmaceutical To Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
17/03/2025 08:05
March 17 (Reuters) - Otsuka Holdings Co Ltd 4578.T: OTSUKA HOLDINGS CO LTD- : TAIHO PHARMACEUTICAL TO ACQUIRE NEXT-GENERATION ADC DRUG DISCOVERY COMPANY ARARIS BIOTECH OTSUKA HOLDINGS CO LTD- SUBSIDIARY TAIHO WILL PAY ARARIS SHAREHOLDERS A $400 MILLION UPFRONT UPON COMPLETION OF ACQUISITION AS WELL AS POTENTIAL ADDITIONAL MILESTONE PAYMENTS OF UP TO $740 MILLION Source text: ID:nTSoq914c8 Further company coverage: 4578.T (Reporting by Rocky Swift) ((rocky.swift@thomsonreuters.com;))
Recent news on Otsuka Holdings
See all newsOtsuka, Ionis' experimental ALS drug meets main goal in late-stage study
Brief: Otsuka Pharmaceutical Announces Ulefnersen Early Access Program For Eligible People Living With FUS-ALS
Brief: Otsuka Pharmaceutical Says Phase 3 Fusion Results For Ulefnersen Met Primary Endpoint
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit In Rezilient3 Phase 3 Trial In First-Line Egfr Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Climb Bio rises after early-stage data for kidney disease drug